Keywords: fda, requests, new, ph, iii, trial, lilly

FDA requests new Ph III trial for Lilly's diabetic retinopathy drug

Article | 09 October 2006

Print This

USA-based drug major Eli Lilly says it is considering its options regarding the further development of its diabetic retinopathy drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in